1/25/22 dc Pharmacist model and shift equity updates
January 25, 2022
From: "David Collette" <david.collette@hhsys.org>
Sent: Tuesday, January 25, 2022 1:39:29 PM
Subject: Pharmacist model and shift equity updates
Pharmacists,
Since we canceled the planned January pharmacist meetings due to the COVID surge, I thought I would give an update on our current status with shift enhancement and pilots aimed at embedding more shift equity into the schedule. Here are a few notes:
1. We are continuing with the Friday pilot (treating Fridays on second shift like a weekend) and the 7on/7off ED position...feedback has been good, but please let me know if you have any input on this pilot
2. A pilot to determine the optimal number of UB pharmacists on second shift will begin 01/31/22
3. When this pilot begins 01/31/22, first shift impact will include:
No overlap from 1230-1345 and 1430-1530
Day shift clinical specialists/UBs should limit consults for second shift to those that are absolutely necessary (ex: pending levels)
4. Tentatively, beginning Feb 21 or 28, the 2 pharmacists moved from 2nd shift will be used to deploy 7 total UB pharmacists on day shift
5. A suggested pilot for the near future involves determining whether or not it is feasible for our Main pharmacists (UB, Central, PSP, Clin Spec) to work every 4th weekend
I hope this updates everyone on the pilots we have in place and planned for the near future. We ask that you be patient, communicate well, and give constructive feedback (especially if you feel workload is unsafe or unbalanced) to your manager, supervisor, lead, or directly to me. Also, please attend one of the pharmacist meetings Feb 17, 18, or 23 (please watch for a calendar invitation soon and accept one of the meetings).
I look forward to working with each of you as we determine the best pharmacist model for optimal patient care and work-life balance. You are welcome to contact me if you have questions or if any of this information is unclear. Please note that all time lines are tentative (goals, not deadlines) and we will have adequate time for analysis of outcomes before we proceed to another pilot.